Eosinophilic esophagitis (EoE) is no longer a rarity in European clinics. Diagnosed increasingly over the past three decades, EoE is commonly managed with pharmacotherapy, elimination diets, and, when indicated, esophageal dilation. A caspase-1 inhibitor, VX-765, is also being investigated in preclinical models as a novel treatment strategy. Yet for many patients, the greatest challenge lies beyond the inflammation.

Unpredictable dysphagia and food impaction drive anxiety, avoidance behaviors, and social withdrawal. Symptoms overlap with gastroesophageal reflux disease (GERD), complicating diagnosis. Delays can carry a cost. A 2025 Swiss study found that women who experienced diagnostic delays reported higher impairment in daily life.

As European clinicians look to optimize care, evidence points to the value of pairing disease control with structured psychosocial support.

European experience suggests the need for a pragmatic shift: Controlling eosinophilic inflammation is necessary but rarely sufficient. Addressing anxiety, phagophobia, and the social constraints of eating can reduce symptom amplification, improve adherence, and help patients regain confidence at mealtimes — not merely achieve histologic remission.

The Changing EoE Landscape in Europe

EoE was first recognized as a distinct disease in 1993, and its incidence has risen markedly in Europe. Typical adults with EoE are aged 30-50 years, male, Caucasian, and often atopic. Food and airborne allergens can trigger eosinophilic inflammation and esophageal irritation, with patients reporting pain and difficulty swallowing, in addition to feeling like food is stuck in their throats — symptoms that also suggest GERD and can blur the diagnostic pathway.

Beyond diagnosis, the day-to-day burden is substantial. “The burden of suffering from EoE stems from multiple factors, including the symptoms of the disease, the anxiety these symptoms cause, and the social consequences of avoidance strategies,” explained Alfredo J. Lucendo, MD, PhD, head of gastroenterology at the General Hospital of Tomelloso, Tomelloso, Spain; principal researcher of the Eosinophilic Inflammation and Mucosal Immunology Research Lab; and past president of the European Society of Eosinophilic Oesophagitis. “Their severity — especially in cases of food impaction — their chronic nature, and the unpredictability of when an episode of dysphagia or food impaction will occur lead patients to experience various psychological responses.”

When Eating Becomes a Stressor

Survey results presented at the European Academy of Allergy and Clinical Immunology Congress 2025 reported that 73% of adults with EoE reported adopting coping mechanisms to navigate meals: taking longer to eat, cutting food into small pieces, avoiding triggers, and planning fluid intake to ease swallowing. These strategies keep patients safe but exact a daily toll.

Swiss data from 2025 also highlighted other underappreciated quality-of-life impacts — such as exertional chest pain in young men that curtails exercise, a key stress reliever. Socially, patients may avoid restaurants, struggle to share meals with family, or fear public episodes of food impaction, contributing to isolation.

Psychological distress and symptom perception can become intertwined.

“Phagophobia — the fear of choking on food — is common among patients with high levels of anxiety, who also tend to report more severe degrees of dysphagia and difficulty swallowing a broader range of foods,” Lucendo said. “The need to be constantly aware of where the food is located while it is being swallowed — so-called food hypervigilance — is associated with high anxiety levels, making the patient more sensitive to all types of sensations during swallowing. As a result, they may perceive any esophageal acid reflux as painful, and even minimal discomfort is experienced more intensely.”

The Psychobiological Loop

Even when inflammation is controlled, distress may not recede. “A vicious circle is created in which unpredictable and sometimes severe physical symptoms like food impaction cause significant psychological deterioration,” Lucendo said. “In turn, this worsens the perception and severity of physical symptoms, even when the esophageal inflammation has been effectively treated.”

Clinicians can help by naming the loop.

“Physicians can have a hugely transformative effect on the health and well-being outcomes of patients with EoE, simply by naming the existence of psychosocial factors,” said Sula Windgassen, PhD, a London-based health psychologist, cognitive-behavioral therapy therapist, and eye movement desensitization and reprocessing therapist who works with gastrointestinal patients. “This can be even more impactful when they explain that psychobiological loops can occur. This means that patients’ psychological experiences while having symptoms can impact the symptoms themselves and perpetuate mood difficulties.”

That framing helps engagement. “When a physician explains the interrelationship between psychology and biology, a referral to a psychologist can feel more relevant and empowering to a patient,” Windgassen added. “It moves away from a patient sensing they’re being told ‘it’s all in your head.’”

Building Comprehensive, Sustainable Care 

In practice, experts recommend a dual focus on disease control and structured psychosocial support:

Control the condition. “It’s essential to ensure that the treatment being administered is effective, therapeutic adherence is adequate, esophageal inflammation is gone, and that there are no strictures or luminal narrowings capable of explaining the presence of physical symptoms,” Lucendo said. Still, a 2024 survey of 228 physicians in 18 European countries found that 21.5% did not prescribe maintenance therapy, raising questions about consistency in long-term care.

Bring in psychology early and purposefully. Ask a psychologist to advise on how you discuss EoE, validate distress, and set expectations. “It can be valuable to get insight from the psychologist about what information may be salient to your treatment and check-in process,” Windgassen said. “What information or support would strengthen the patient’s engagement in psychological therapy? Multidisciplinary team meetings, where processes from gastrointestinal psychotherapy are disseminated and formulations shared, can help with this.”

Assemble the right team. “Although not required in all cases, the comprehensive management of EoE may need to involve, at minimum, access to a nutritionist, a psychologist, and a speech therapist,” Lucendo said. A social worker can identify community resources, support groups, and programs that connect patients with peers who understand their challenges.

Make a tracking routine. To save time and standardize follow-up, use brief, validated questionnaires to capture both symptoms and quality of life before each visit. “These serve as an objective method to evaluate the impact of the disease and to detect any negative emotional effects, which should then be explored in more detail by encouraging the patient to share their concerns,” Lucendo advised.

Crucially, tell patients that distress has a medical basis tied to EoE’s pathophysiology and lived constraints — and that it can improve with targeted strategies. As Lucendo summed up: “We must help patients understand that these symptoms, far from being a sign of personal weakness, are a direct and common consequence of the emotional and social impact of EoE.”

Lucendo and Windgassen reported having no relevant financial relationships.